GeneDx Holdings (WGS) Current Assets (2020 - 2026)

GeneDx Holdings (WGS) has reported Current Assets for 7 consecutive years, with $246.4 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Assets rose 20.27% year-over-year to $246.4 million in Q2 2026; TTM through Jun 2026 was $246.4 million, a 20.27% increase from a year earlier, with the FY2025 full-year figure at $268.3 million, up 35.52% from the prior year.
• Current Assets was $246.4 million for Q2 2026 at GeneDx Holdings, down from $270.6 million in the prior quarter.
• Over five years, Current Assets peaked at $410.4 million in Q1 2022 and troughed at $162.2 million in Q2 2024.
• A 5-year average of $240.8 million and a median of $219.5 million in 2023 frame the typical range for Current Assets.
• The widest YoY moves for Current Assets: up 306.72% in 2022, down 56.03% in 2022.
• Over 5 years, Current Assets stood at $212.6 million in 2022, then retreated by 14.24% to $182.3 million in 2023, then gained by 8.57% to $198.0 million in 2024, then surged by 35.52% to $268.3 million in 2025, then decreased by 8.17% to $246.4 million in 2026.
• The last three Current Assets figures came in at $246.4 million (Q2 2026), $270.6 million (Q1 2026), and $268.3 million (Q4 2025), per Business Quant data.